510(k) Report

510(k) · Cleared

Cleared

Checkpoint with Accustim Technology

K061365510(k) TraditionalCleared Jul 12, 200657-day reviewClass II21 CFR 874.1820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ndi Medical, LLC · ETN Stimulator, Nerve

Cleared on Jul 12, 2006 as substantially equivalent to K905045 (Aaron Medical Industries, 1991) and 1 other predicate after a 57-day review. Its family tree reaches back 1 generation to 1991. 5 later devices descend from it.

Decided
Jul 12, 2006
Review
57 days
Class
Class II
Product code
ETN
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K905045 (1991). 2 ancestors in all. 5 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1994: 1 other ancestor2009: 1 descendant cleared2015: 1 descendant cleared2021: 1 descendant cleared2020: 1 descendant cleared2026: 1 descendant clearedK905045 · Nerve Locator/Stimulator · Aaron Medical Industries · 19911990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 3 descendants3 generations forward: 1 descendant K905045 · Nerve Locator/Stimulator · Aaron Medical Industries · 19910
  1. Root · 1 generation backK905045 Nerve Locator/StimulatorAaron Medical Industries · 1991
  2. This deviceK061365 Checkpoint with Accustim TechnologyNdi Medical, LLC · 2006
  3. Descendant · cites it directly · 4 of its ownK092292 CheckpointNdi Medical, LLC · 2009
  4. Descendant · 2 generations on · 1 of its ownK150005 Checkpoint, Checkpoint Head & NeckNdi Medical, LLC · 2015
  5. Descendant · 3 generations on · 0 of its ownK253536 Evala Nerve Stimulator (EPNR002)Epineuron Technologies, Inc. · 2026
  6. Descendant · 2 generations on · 0 of its ownK212355 Checkpoint Guardian Intraoperative Lead, Medium, Checkpoint Guardian…Checkpoint Surgical · 2021 · Recalled
  7. Descendant · 2 generations on · 0 of its ownK200886 StimSiteAllotrope Medical, Inc. · 2020

Most influential descendants

Showing 5 of 5 · See all
  • K092292CheckpointNdi Medical, LLC · 2009 · cites it directly4descendants
  • K150005Checkpoint, Checkpoint Head & NeckNdi Medical, LLC · 2015 · 2 generations on1descendant
  • K253536Evala Nerve Stimulator (EPNR002)Epineuron Technologies, Inc. · 2026 · 3 generations on0descendants
  • K212355Checkpoint Guardian Intraoperative Lead, Medium, Checkpoint Guardian Intraoperative…Checkpoint Surgical · 2021 · 2 generations on0descendants
  • K200886StimSiteAllotrope Medical, Inc. · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K905045Nerve Locator/StimulatorAaron Medical Industries1991—
0 (this device)K061365Checkpoint with Accustim TechnologyNdi Medical, LLC2006—
+1K092292CheckpointNdi Medical, LLC2009—
+2K150005Checkpoint, Checkpoint Head & NeckNdi Medical, LLC2015—
+3K253536Evala Nerve Stimulator (EPNR002)Epineuron Technologies, Inc.2026—
+2K212355Checkpoint Guardian Intraoperative Lead, Medium, Checkpoint Guardian…Checkpoint Surgical20212
+2K200886StimSiteAllotrope Medical, Inc.2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201510
202010
202110
202610
FIG. 1 — Lineage of K061365, 1991–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ETN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new ETN device

  1. #1 K251672 NIM Essence™ EMG Endotracheal Tube…score 12.3 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K905045Nerve Locator/Stimulator
Summary page 1
…EVICES * Medtronic Xomed Vari-Stim III (pre-amendment device) Medtronic Xomed (originally Concept Medical) * Aaron Neuro-Pulse (K905045), Aaron Medical * Xomed Nerve Integrity Monitor Response 2.0 and NIM2-XL (K934426) Medtronic Xomed-Tr…
Aaron Medical Industries1991—
*K934426Nerve Integrity Monitor-2 (Nim-2 XL)
Summary page 1
…Xomed (originally Concept Medical) * Aaron Neuro-Pulse (K905045), Aaron Medical * Xomed Nerve Integrity Monitor Response 2.0 and NIM2-XL (K934426) Medtronic Xomed-Treace, Inc. 4. DEVICE DESCRIPTION The CheckpointTM is a small handheld device used…
Xomed-Treace, Inc.1994—
*—Medtronic Xomed Vari-Stim III
Named without a submission number
—

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K092292CheckpointNdi Medical, LLC20094

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K092292 (Ndi Medical, LLC, 2009) has gone furthest, with 4 descendants of its own.

How does its category compare?

All ETN devices

ETN Stimulator, Nerve: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · ETN

1in 2025

2007: 22008: 22009: 52010: 32011: 92012: 72013: 12014: 22015: 12016: 22020: 12021: 12022: 22023: 52024: 22025: 12026 (partial year): 2
2007high 9 (2011) · low 0 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ETN

98in 2023

2009: 115 days median2010: 168 days median2011: 115 days median2012: 179 days median2023: 98 days median
2007high 179 (2012) · low 98 (2023)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · ETN

1in 2023

2008: 12010: 12016: 12019: 22020: 12021: 12023: 1
2007high 2 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · ETN

1,145in 2025

2007: 52008: 52009: 222010: 262011: 552012: 1872013: 2702014: 1372015: 2022016: 1452017: 1172018: 2502019: 3142020: 2382021: 1972022: 2472023: 3902024: 7482025: 1,145
2007high 1,145 (2025) · low 5 (2007)2025

MAUDE reports naming product code ETN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—05
20082—15
20095115022
20103168126
20119115055
201271790187
20131—0270
20142—0137
20151—0202
20162—1145
20170—0117
20180—0250
20190—2314
20201—1238
20211—1197
20222—0247
20235981390
20242—0748
20251—01,145
20262—0—

What is it indicated for?

The CheckpointTM is a single-use device intended to provide electrical stimulation of exposed motor nerves or muscle tissue to locate and identify nerves and to test nerve and muscle excitability.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061365: Checkpoint with Accustim Technology.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061365

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026